Skip to main content
Equibles

MORGAN STANLEY

Position in ZYME — Zymeworks Inc.

CIK 895421 NEW YORK, NY
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$58,325,133
-$3,788,288 QoQ
Shares Held
2,231,260
-10.1% QoQ
Ownership
3.14%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 202 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ZYME ranks #55 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in ZYME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $58,325,133 2,231,260
2026-03-31 $62,113,421 2,480,568
2025-12-31 $68,275,794 2,593,080
2025-09-30 $68,056,709 3,984,585
2025-06-30 $52,429,052 4,177,614
2025-03-31 $48,514,941 4,073,463
2024-12-31 $61,509,034 4,201,437
2024-09-30 $64,091,203 5,106,869
2024-06-30 $36,077,691 4,239,447
2024-03-31 $53,769,232 5,111,144
2023-12-31 $50,508,759 4,861,286
2023-09-30 $28,433,108 4,484,718
2023-06-30 $47,397,292 5,485,798
2023-03-31 $50,292,239 5,563,301
2022-12-31 $43,806,765 5,573,380